Analysts' recommendations: Avinger, Inc.

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

More recommendations

Managers and Directors: Avinger, Inc.

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	04/08/2024

More insiders

Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Other stock markets 21:00:00 14/02/2025 GMT			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

19/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
16/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.38M 2.21M 2.03M 3.81M 261M 3.87M 26.26M 10.26M 128M 10.16M 9.94M 443M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.27M 10.48M 9.61M 18.06M 1.24B 18.34M 124M 48.61M 607M 48.15M 47.12M 2.1B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

19/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
16/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
10/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
10/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
10/02/25	Avinger, Inc. Announces Executive Changes	CI
24/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/12/24	US Futures Tread Water Ahead of Holiday Break	MT
23/12/24	Iberdrola Completes Merger with Avangrid	MT
07/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
07/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
07/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
07/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
07/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Avinger, Inc. Share Price

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news : Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
23/01/25	Himanshu Patel	Sell	Founder	2,215	0.0669%
23/01/25	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%
23/01/25	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-95.95%	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.58%	-0.54%	-20.02%	-21.59%	13.29B
IRAY GROUP	-0.07%	+1.96%	+47.21%	-10.31%	3.94B
IRADIMED CORPORATION	+0.67%	-2.62%	+66.94%	+108.31%	1.21B
SONOSCAPE MEDICAL CORP.	-3.46%	-4.08%	-43.09%	-62.00%	1.14B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-1.62%	-2.27%	-42.08%	-48.66%	1.07B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	-3.98%	-4.44%	-46.64%	-	900M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-3.75%	-8.19%	+27.54%	+74.96%	450M
CAPSOVISION, INC.	-1.67%	-3.28%	+51.99%	-	324M
FISCHER MEDICAL VENTURES LIMITED	-1.90%	-3.12%	-60.45%	+228.57%	257M
Average	-4.01%	-0.88%	-1.86%	+21.67%	2.26B
Weighted average by Cap.	-2.61%	-4.24%	-5.38%	-10.63%

	2022	2023
Net sales	8.27M 7.27M 6.76M 6.2M 11.65M 797M 11.83M 80.24M 31.35M 392M 31.06M 30.39M 1.35B	7.65M 6.72M 6.25M 5.74M 10.78M 737M 10.94M 74.22M 29M 362M 28.73M 28.11M 1.25B
Net income	-17.62M -15.48M -14.39M -13.21M -24.82M -1.7B -25.2M -171M -66.78M -834M -66.16M -64.73M -2.88B	-18.32M -16.09M -14.96M -13.73M -25.8M -1.76B -26.2M -178M -69.42M -867M -68.77M -67.29M -3B
Net Debt	1.76M 1.54M 1.43M 1.32M 2.47M 169M 2.51M 17.03M 6.65M 83.14M 6.59M 6.45M 287M	10.12M 8.89M 8.27M 7.59M 14.25M 975M 14.47M 98.16M 38.35M 479M 37.99M 37.17M 1.66B

3 years	0.36	14
5 years	0.36	312
10 years	0.36	685,202.74